Current stock page

Financial Data

PGEN Financial Data

Revenue · Earnings · Margins · Balance Sheet · Cash Flow

HealthcareBiotechnologyScore data as of Nov 13, 2026

PGENPrecigen, Inc.

Healthcare / Biotechnology

Low Priority

In Line With Peers

NeutralEdge 5/10
$4.54−$0.12 (−2.58%)

Latest quote

  • Momentum
    55
  • Value
    63
  • Quality
    60
  • Risk resilience
    31
  • Sentiment
    —
algovestiq.comScore data as of Nov 13, 2026

Financial Data Overview

Detailed revenue, earnings, margins, balance sheet, cash flow, valuation metrics, technical indicators, and risk measures for deeper research.

Quarterly periods
8
Fundamental metrics
10
Technical indicators
12
Risk measures
6

Quarterly Financial Statements

Updated Nov 16, 2026.

Income statement
8 periods
Metric2026-09-302026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-31
Revenue$74.15M$54.98M$23.25M$4.57M$2.92M$856K$1.34M$1.19M
Gross Profit$67.64M$52.17M$20.38M$2.65M$1.57M-$699K-$78K$21K
Operating Income$38.65M$22.64M-$5.99M-$21.67M-$34.48M-$31.76M-$22.6M-$28.52M
Net Income$35.77M$20.07M-$7.93M-$23.5M-$146.34M-$26.64M-$54.15M-$19.73M
EPS$0.1$0.06-$0.03-$0.07-$1.1-$0.09-$0.18-$0.07
Cash flow statement
8 periods
Metric2026-09-302026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-31
Operating Cash Flow$11.88M-$17.81M-$43.83M-$23.46M-$29.07M-$18.98M-$16.33M-$8.24M
Capital Expenditure-$435K-$392K-$258K-$622K-$389K-$966K-$622K-$1.03M
Free Cash Flow$11.45M-$18.2M-$44.09M-$24.08M-$29.46M-$19.94M-$16.95M-$9.27M
Net Cash Provided By Operating Activities$11.88M-$17.81M-$43.83M-$23.46M-$29.07M-$18.98M-$16.33M-$8.24M
Balance sheet
8 periods
Metric2026-09-302026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-31
Total Assets$212.1M$170.3M$138.63M$155.51M$171.26M$101.9M$128.79M$145.27M
Total Debt$98.61M$98.35M$98.25M$98.29M$98.19M$5.15M$5.42M$5.5M
Cash And Cash Equivalents$14.96M$16.33M$7.48M$30.23M$14.32M$13.76M$6.06M$29.52M
Total Liabilities$128.31M$126.72M$118.39M$134.59M$129.4M$138.68M$142.85M$106.75M
Total Stockholders Equity$83.79M$43.58M$20.24M$20.91M$41.87M-$36.78M-$14.06M$38.51M
Key financial metrics
8 periods
Metric2026-09-302026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-31
P/E ratio72.83———————
P/B ratio21.2161.9964.1946.427.33———
P/S ratio10.36———————
Debt To Equity1.182.264.864.72.35——0.14
Free Cash Flow Yield-4.22%-4.29%-9.05%-9.32%-6.61%-13.08%-20.01%—
Financial ratios
8 periods
Metric2026-09-302026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-31
P/E ratio72.83———————
P/B ratio21.2161.9964.1946.427.33———
P/S ratio10.36———————
Return On Equity29.12%-3.62%-10.10%-11.99%-5.90%——-3.28%
Debt To Equity1.182.264.864.72.35——0.14

Current Stock Metrics

Current fundamental, technical, and risk readings in one place.

Fundamental metrics
MetricValue
Pe66.47x
Pb19.41x
Revenue Growth Yoy2437.58%
EPS Growth Yoy109.09%
Gross Margin91.01%
Operating Margin21.43%
ROE57.93%
ROIC18.28%
Debt To Equity1.18
FCF Yield-4.60%

As of Nov 13, 2026

Technical indicators
MetricValue
Close$4.54
Volume3.78M
RSI (14)34.19
MACD-0.69
MACD signal-0.61
MACD histogram-0.07
ADX (14)28.76
SMA (50)$6.74
SMA (200)$5.28
ATR (14)$0.50
Historical volatility (annualized)127.00%
Volume (20-day average)7.9M

As of Nov 13, 2026

Risk measures
MetricValue
Resilience score31/100
Beta1.62
Annual volatility85.43%
Max Drawdown-50.70%
Sharpe Ratio0.57
VaR (95%, 1-day)-7.17%

As of Nov 13, 2026

Detailed Metrics

Additional measures remain available here while the decision pages stay focused.

Additional fundamental metrics

No additional fundamental metrics are available.

Additional technical indicators

No additional technical indicators are available.

Additional risk measures

No additional risk measures are available.

PGEN Financial Data FAQ

What is Precigen, Inc.'s revenue?

Precigen, Inc.'s revenue is one of the core financial data points for PGEN. Use it with revenue growth, margins, and EPS to understand whether sales are translating into earnings power.

Is Precigen, Inc.'s revenue growing?

Revenue growth shows whether Precigen, Inc. is expanding from prior periods. Compare growth with margins and free cash flow because faster sales growth is more valuable when profitability holds up.

What is PGEN's EPS?

PGEN's EPS, or earnings per share, helps connect net income to each share. EPS should be compared with EPS growth, P/E ratio, and analyst expectations.

What is Precigen, Inc.'s net income?

Precigen, Inc.'s net income shows profit after costs, taxes, and other expenses. It should be read with revenue, operating margin, EPS, and free cash flow.

How much free cash flow does Precigen, Inc. generate?

Free cash flow shows how much cash Precigen, Inc. generates after capital spending. It is useful for judging reinvestment capacity, buybacks, debt reduction, and valuation support.

How much cash and debt does Precigen, Inc. have?

Cash and debt help frame PGEN's balance-sheet flexibility. Compare liquidity and leverage with free cash flow and profitability before judging financial strength.